Financials
- Market Capitalization 7.88 M
- Employee 12
- Founded 2011
- CEO N/A
- Website www.skyebioscience.com
- Headquarter Nevada, United States
- FIGI BBG00433GZN1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.07
ratio cours/chiffre d'affaires
82.43
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4816 | SNGX Soligenix, Inc. - Common Stock | 0.38 USD | 0.00% | -2.56% | +5.56% | -66.37% | 8.27 M USD | ||
| 4819 | ALZN Alzamend Neuro, Inc. - Common Stock | 1.68 USD | +0.60% | +7.69% | +32.28% | -30.00% | 8.05 M USD | ||
| 4831 | ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.45 USD | -0.68% | -2.68% | +3.57% | -24.48% | 7.64 M USD | ||
| 4832 | AIM AIM ImmunoTech Inc. Common Stock | 0.25 USD | 0.00% | -3.85% | +4.17% | -90.20% | 7.61 M USD |